Reporting Manager
Sphera Funds Management Ltd.
Symbol
OTLK
Shares outstanding
67,246,397 shares
Disclosed Ownership
3,153,856 shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
05 Feb 2026, 11:48:52 UTC
Date of event
31 Dec 2025
Previous filing
10 Apr 2025

Quoteable Key Fact

"SPHERA FUNDS MANAGEMENT LTD. disclosed 4.7% ownership in Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK) on 31 Dec 2025."

Quick Takeaways

  • SPHERA FUNDS MANAGEMENT LTD. filed SCHEDULE 13G/A for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK).
  • Disclosed ownership: 4.7%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 10 Apr 2025.
  • Current filing was accepted on 05 Feb 2026, 11:48.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sphera Funds Management Ltd. 4.7% 3,153,856 0 3,153,856 /s/ Adi Hanetz Adi Hanetz / General Counsel
Sphera Global Healthcare GP Ltd. 4.7% 3,153,856 0 3,153,856 /s/ Adi Hanetz Adi Hanetz / General Counsel
Sphera Global Healthcare Management LP. 4.7% 3,153,856 0 3,153,856 /s/ Adi Hanetz Adi Hanetz / General Counsel